Acetic Acid Butyl Ester

Acetic Acid Butyl Ester

SCHEMBL99360

C=C.CCCCOC(C)=O.CCOCC.OCCO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.67
TSHR P16473 6/20 0.53
HPGD P15428 1/20 0.44
ATM Q13315 1/20 0.42
LMNA P02545 1/20 0.41
HSD17B10 Q99714 1/20 0.41
THRB P10828 1/20 0.39
HCAR2 Q8TDS4 1/20 0.38
ACHE P22303 7/20 0.38
NAAA Q02083 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid Butyl Ester SCHEMBL11586521 1.00 ALDH1A1 (0.67) ALDH1A1TSHRHPGDATMLMNA
Acetic Acid Butyl Ester SCHEMBL3830941 1.00 ALDH1A1 (0.67) ALDH1A1TSHRHPGDATMLMNA
Acetic Acid Butyl Ester SCHEMBL21930789 0.96 ALDH1A1 (0.72) ALDH1A1TSHRHPGDATMLMNA
Acetic Acid Butyl Ester SCHEMBL23847 0.96 ALDH1A1 (0.72) ALDH1A1TSHRHPGDATMLMNA
Acetic Acid Butyl Ester SCHEMBL446697 0.94 ALDH1A1 (0.69) ALDH1A1TSHRHPGDATMLMNA
Hexyl Acetate SCHEMBL6559242 0.93 ALDH1A1 (0.57) ALDH1A1TSHRTHRBHCAR2ACHE
Acetic Acid Butyl Ester SCHEMBL4872777 0.92 ALDH1A1 (0.78) ALDH1A1TSHRHPGDATMLMNA
Acetic Acid Butyl Ester SCHEMBL17797774 0.92 ALDH1A1 (0.78) ALDH1A1TSHRHPGDATMLMNA
Acetic Acid Butyl Ester SCHEMBL282613 0.91 ALDH1A1 (0.60) ALDH1A1TSHRHPGDATMLMNA
Acetic Acid Butyl Ester SCHEMBL487270 0.91 ALDH1A1 (0.60) ALDH1A1TSHRHPGDATMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3503869-B1 SUSPENSION COMPOSITIONS AND USE THEREOF FOR COUNTERACTING MALODOUR AQDOT LTD (GB) 2026-03-04 EP claimed
WO-2025124777-A1 DETERGENT OR CLEANING AGENT MOLDED BODIES HENKEL AG & CO. KGAA (DE) 2025-06-19 WO claimed
US-12331270-B2 Solvent mixture for the removal of silicone conformal coatings from a printed circuit board NuGeneration Technologies, LLC (US) 2025-06-17 US claimed
US-20240384472-A1 DRAINAGE AIDS AND THE USE THEREOF ECOLAB USA INC (US) 2024-11-21 US claimed
CN-115812089-B Conductive ink 株式会社大赛璐 2024-10-18 CN claimed
EP-3781373-B1 FINISHING MEDIUMS AND FINISHING SUSPENSIONS POSTPROCESS TECH INC (US) 2024-10-02 EP claimed
CN-109790382-B Solvent system for synthesizing poly (amic acid) and polyimide polymers 陶氏环球技术有限责任公司 2024-09-13 CN claimed
US-20240132810-A1 Compositions for the Removal of Silicone Deposits NuGeneration Technologies, LLC dba NuGenTec (US) 2024-04-25 US claimed
US-11945919-B2 Method for producing a population of particles of polyvinylidene difluoride or of particles of a copolymer comprising polyvinylidene difluoride EVONIK OPERATIONS GMBH (DE) 2024-04-02 US claimed
US-11944001-B2 Luminescent material, method of preparing the same, and light-emitting device including the luminescent material SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-03-26 US claimed
US-20070193960-A1 Process for recovering organic compounds from aqueous streams containing same DOW GLOBAL TECHNOLOGIES INC. 2007-08-23 US claimed
EP-1720896-A1 PROCESS FOR REMOVING WATER FROM AQUEOUS SOLUTIONS OF PROTEINS The Dow Global Technologies Inc. (US) 2006-11-15 EP claimed
EP-1720897-A2 METHOD FOR THE EXTRACTION OF INTRACELLULAR PROTEINS FROM A FERMENTATION BROTH The Dow Global Technologies Inc. (US) 2006-11-15 EP claimed
EP-1720814-A2 PROCESS FOR RECOVERING ORGANIC COMPOUNDS FROM AQUEOUS STREAMS CONTAINING SAME The Dow Global Technologies Inc. (US) 2006-11-15 EP claimed
US-20060063858-A1 Ink composition and color filter including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2006-03-23 US claimed
US-20050227897-A1 Glycol ether miticides and anti-allergen treatments CLOROX COMPANY, THE 2005-10-13 US claimed
WO-2005092915-A1 PROCESS FOR REMOVING WATER FROM AQUEOUS SOLUTIONS OF PROTEINS DOW GLOBAL TECHNOLOGIES INC. (US) 2005-10-06 WO claimed
WO-2005087692-A2 PROCESS FOR RECOVERING ORGANIC COMPOUNDS FROM AQUEOUS STREAMS CONTAINING SAME DOW GLOBAL TECHNOLOGIES INC. (US) 2005-09-22 WO claimed
WO-2005087791-A2 METHOD FOR THE EXTRACTION OF INTRACELLULAR PROTEINS FROM A FERMENTATION BROTH DOW GLOBAL TECHNOLOGIES INC. (US) 2005-09-22 WO claimed
US-6283663-B1 Paint applicator system Russo, Timothy M. 2001-09-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11944001-B2 Luminescent material, method of preparing the same, and light-emitting device including the luminescent material SLFN12, XRN2, ALG3 ALDH1A1 768/4885TSHR 2199/4885HPGD 3710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.